Diabetes – The NET Effect

Diabetes – The NET Effect

Updated January 2026Originally published September 2018. My chest infection is now settled, as too is the excitement and apprehension behind my first ever Ga68 PET - the outcome of that is still a work in progress. Earlier this year, my thyroid 'lesion' on watch and wait was given a 'damping down' with the prescription of a thyroid hormone supplement but I await a re-ignition of that small bush fire downstream. Bubbling behind the scenes and clamouring for attention is the spiking of my blood glucose test results and I was very recently declared 'at risk' for diabetes with a score…
Read More
Chocolate – the NET effect

Chocolate – the NET effect

I've always had a 'sweet tooth' and the softer the sweet the better - toffee, marshmallows, chocolate, jelly babies, jelly beans, fruit pastilles, fudge, liquorice allsorts, 'tablet' and macaroon bars (both from Scotland), are all on my list of favourites.  In terms of desserts, I love those too - ice cream, cheese cake, meringue, cake, sponge with custard, the list is endless. And of course a hot drink isn't complete without a biscuit (or three....). Don't get me wrong, I'm not stuffing my face with sweet stuff 24/7, however I do need my sugar 'fix' now and then. I'm not a…
Read More
GLP-1 receptor agonists (e.g. semaglutide) for adults with type 2 diabetes/weight loss – The Neuroendocrine Tumour (NET) Effect

GLP-1 receptor agonists (e.g. semaglutide) for adults with type 2 diabetes/weight loss – The Neuroendocrine Tumour (NET) Effect

Before you read this… This article is provided to support understanding of how GLP-1 receptor agonists (for example, semaglutide) may relate to type 2 diabetes, weight loss, and neuroendocrine tumours (NETs). It is intended for general education only and is not suggesting that these medicines are suitable or unsuitable for you or anyone else. Every case is different. Only your own specialist team can assess your individual situation and advise on the risks, benefits, and alternatives of GLP-1 receptor agonists or any other treatment in the context of your health and any NET diagnosis.   Updated 24 Dec 2025 Novo…
Read More